weight loss drug news today glp-1 New oral delivers up to 12% in 36 weeks GLP-1 drugs like Ozempic linked
Description
People with obesity are more likely to develop RA and then have worse RA symptoms
Kobilka B
We could expect from early treatment with oral semaglutide and other GLP-1 analogues a better control of cardiovascular risks as a result of its actions exerted before atherosclerosis develops, in addition to the benefits of superior glucose control and weight loss
Most people start with a low dose and slowly increase it
In the study, researchers at Washington University School of Medicine in St
